AP Pharma

A.P. Pharma Submits New Drug Application for APF530 in Chemotherapy-Induced Nausea and Vomiting
Yahoo
Mon, 05/18/09 - 09:34 am
AP Pharma
FDA
NDA
APF530
AP Pharma gets Nasdaq delisting warning
Bizjournals.com
Tue, 04/7/09 - 11:21 am
AP Pharma
NASDAQ

Pages